Cargando…

Deprescribing in older people: helpful tools and proton pump inhibitors

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738701/ https://www.ncbi.nlm.nih.gov/pubmed/33363298 http://dx.doi.org/10.18773/austprescr.2020.070

Ejemplares similares

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Discussing proton pump inhibitor deprescribing: the views of Danish GPs and older patients
por: Thompson, Wade, et al.
Publicado: (2020)

Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors
por: Calvini, Giulia, et al.
Publicado: (2023)

Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients
por: Zirk-Sadowski, Jan, et al.
Publicado: (2017)

Deprescribing in old people: Only for chronic medication?
por: Llor, Carl, et al.
Publicado: (2022)

Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
por: Aubert, Carole E., et al.
Publicado: (2023)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Peer-Led Education Expedites Deprescribing Proton Pump Inhibitors for Appropriate Veterans
por: Bowman, Mary H.
Publicado: (2020)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

Proton-pump inhibitors should be strictly prescribed in clinic
por: Yang, Xuesong, et al.
Publicado: (2022)

Deprescribing Statins and Proton Pump Inhibitors in Nursing Home Residents; a Pragmatic Exploratory Study
por: Visser, Anne G. R., et al.
Publicado: (2021)

Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural Veterans
por: Bhardwaj, Sonia, et al.
Publicado: (2022)

COVID-19 Mortality: The Culprit May Not Be Proton Pump Inhibitors
por: Duan, Zhihui, et al.
Publicado: (2022)

The costly case of proton-pump inhibitors: a single-center experience
por: Suresh Kumar, Vishnu Charan, et al.
Publicado: (2020)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
por: Homolak, Jan, et al.
Publicado: (2021)

The Necessity of Validated Questionnaires: Determining Accurate Responses to Proton Pump Inhibitor Use
por: Jung, Kee Wook
Publicado: (2012)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
por: Hsieh, Yu-Hsi, et al.
Publicado: (2013)

Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
por: Tariq, Muhammad Ali, et al.
Publicado: (2022)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015)

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
por: Savarino, Edoardo, et al.
Publicado: (2016)

Subacute cutaneous lupus erythematosus due to proton pump inhibitor intake: case report and literature review
por: Reich, Adam, et al.
Publicado: (2012)

Unintended effects of proton pump inhibitors (PPIs) in patients with glioblastoma (GBM): A double-edged sword
por: Castro, Michael P
Publicado: (2022)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Person-Centred Care Including Deprescribing for Older People
por: Smith, Heather, et al.
Publicado: (2019)

Older people’s attitudes towards deprescribing cardiometabolic medication
por: Crutzen, Stijn, et al.
Publicado: (2021)

Association between Parkinson's disease and proton pump inhibitors therapy in older people
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?
por: Tomita, Toshihiko, et al.
Publicado: (2011)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Rutin exerts antiulcer effect by inhibiting the gastric proton pump
por: Dubey, Shagun, et al.
Publicado: (2013)

Meta-analysis associates proton pump inhibitor use with higher pneumonia risk in cirrhotic patients: mining for “diamonds” in the coal
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Non-peer-reviewed data, effect measures, and meta-regression analysis on proton pump inhibitor use and COVID-19
por: Wu, Dan-Na, et al.
Publicado: (2022)

Who has the guts to deprescribe proton pump inhibitors? A pharmacist‐led intervention in a long‐term care facility setting
por: Tandun, Rachel, et al.
Publicado: (2019)

Deprescribing in Frail Older People: A Randomised Controlled Trial
por: Potter, Kathleen, et al.
Publicado: (2016)

Attitudinal predictors of older peoples’ and caregivers’ desire to deprescribe in hospital
por: Scott, Sion, et al.
Publicado: (2019)

Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply
por: Nonaka, Takashi, et al.
Publicado: (2011)

How to deprescribe esketamine in resistant depression? A point of view after first clinical uses
por: Taillefer de Laportalière, T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_50n6lt6n8186ealf0k08kcq2iu